Silver Spring, Maryland–(ENEWSPF)–September 19, 2014. The U.S. Food and Drug Administration yesterday approved Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
